Form 4 for ABT Abbott Laboratories
Accepted 2023-03-02 00:00:00 ET · period of report 2023-02-28 · accession 0001415889-23-003918 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-02 | 2023-02-28 | ABT | Tyler Julie L. | SVP | F - Tax | $99.77 | -1,209 | 39.7K | -3% | -$120.6K | |
| 2023-03-02 | 2023-03-01 | ABT | Tyler Julie L. | SVP | S - Sale | $100.70 | -525 | 39.2K | -1% | -$52.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares without par value | 2023-02-28 | F | D | 1,209 | $99.77 | 39,687 | D | — | — | |
| 2 | Common | Common shares without par value | 2023-03-01 | S | D | 525 | $100.70 | 39,162 | D | — | — |